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picomplexan parasites exhibit a unique form of
substrate-dependent motility, gliding motility, which
is essential during their invasion of host cells and
during their spread between host cells. This process is
dependent on actin ﬁlaments and myosin that are both
located between the plasma membrane and two underlying
membranes of the inner membrane complex. We have
identiﬁed a protein complex in the apicomplexan para-
site 
 
Toxoplasma gondii
 
 that contains the class XIV myosin
required for gliding motility, TgMyoA, its associated light
A
 
chain, TgMLC1, and two novel proteins, TgGAP45 and
TgGAP50. We have localized this complex to the inner
membrane complex of 
 
Toxoplasma
 
, where it is anchored in
the membrane by TgGAP50, an integral membrane glyco-
protein. Assembly of the protein complex is spatially
controlled and occurs in two stages. These results provide
the ﬁrst molecular description of an integral membrane
protein as a speciﬁc receptor for a myosin motor, and further
our understanding of the motile apparatus underlying gliding
motility in apicomplexan parasites.
 
Introduction
 
The human and animal pathogen 
 
Toxoplasma gondii
 
 is an
obligate intracellular parasite of the phylum Apicomplexa,
which also includes 
 
Plasmodium
 
, the causative agent of malaria,
as well as 
 
Eimeria
 
 and 
 
Cryptosporidium
 
, causative agents of
enteritis. These protozoan parasites have to be motile in order
to escape their host cell at the end of infection and invade
new host cells, yet they lack the structures normally associated
with cell motility, such as cilia, flagella, pseudopodia, or
lamellipodia. Instead, these organisms move by a unique
process called gliding motility, a substrate-dependent process
characterized by circular and forward twisting movements
(Hakansson et al., 1999). The process of gliding motility is
still poorly defined, and only some of the key players have
been identified to date. An actin–myosin-based motility system
has been implicated in movement and host cell invasion of
 
Toxoplasma
 
, 
 
Cryptosporidium
 
, and 
 
Plasmodium
 
 using F-actin
destabilizing agents and inhibitors of myosin function (Miller
et al., 1979; Dobrowolski and Sibley, 1996; Dobrowolski et
al., 1997; Forney et al., 1998; Pinder et al., 1998; Kappe et
al., 1999; Wetzel et al., 2003). In 
 
Toxoplasma
 
, gene disruption
experiments indicate that its myosin-A isoform (TgMyoA;
Meissner et al., 2002), a class XIV myosin, and its associated
light chain TgMLC1 (Herm-Gotz et al., 2002) are critical
for the gliding motility of the parasite. For that reason this
complex has been referred to as the glideosome (Opitz and
Soldati, 2002).
The cell wall or pellicle of apicomplexan parasites consists
of the plasma membrane and the closely associated, flattened
cisternae of the inner membrane complex. Both actin and
the myosin-A homologues have been localized to the space
between the plasma membrane and the inner membrane
complex of 
 
Toxoplasma
 
 and 
 
Plasmodium
 
 (Dobrowolski et
al., 1997; Pinder et al., 1998). In 
 
Toxoplasma
 
, actin fila-
ments appear to be associated with the plasma membrane of
the parasite through an interaction with the cytoplasmic tail
of the transmembrane adhesin MIC2, which in turn may be
mediated by the glycolytic enzyme aldolase (Jewett and Sibley,
2003). TgMyoA was originally also believed to be associated
with the plasma membrane (Dobrowolski et al., 1997).
However, more recent evidence in 
 
Plasmodium
 
 
 
yoelii
 
 suggests
that its myosin-A is associated with the inner membrane
complex, as judged by the localization of MTIP, a myosin
light chain-like protein that interacts with the myosin-A tail
(Bergman et al., 2003).
The manner in which the apicomplexan myosins associate
with membranes is not known. A dibasic motif in the carboxy
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terminus of TgMyoA has been found to be essential for lo-
calization to the pellicle and has been proposed to mediate
association with membranes (Hettmann et al., 2000). As
TgMyoA is easily extracted using high pH, it appears to be
a peripheral membrane protein (Hettmann et al., 2000).
However, it is not known whether its membrane association
Figure 1. GAP45 is associated with the inner membrane complex of T. gondii. (A) Distribution of TgGAP45 was compared with that of the 
plasma membrane protein SAG1 in control cells and in parasites treated with C. septicum  -toxin. In untreated cells, the plasma membrane 
protein SAG1 is evenly distributed over the parasite circumference, whereas TgGAP45 distribution reveals an anterior gap (arrows) consistent 
with localization to the inner membrane complex. In toxin-treated parasites, the plasma membrane is markedly distended, whereas the 
distribution of TgGAP45 is not affected, confirming its association with the inner membrane complex. Bars, 4  m. (B) Diagram illustrates the 
basic elements of the Toxoplasma pellicle: the plasma membrane, the two membranes of the inner membrane complex, the membrane skeleton, 
and the subpellicular microtubules. Isolated pellicle preparations were incubated with control antiserum or TgGAP45 antiserum, followed by 
goat anti–rabbit secondary antibodies conjugated to 10-nm gold. The arrowhead indicates the plasma membrane, the arrows the gold particles, 
and the asterisks the subpellicular microtubules. Bars, 150 nm. (C) Multiple alignment of GAP45 sequences from different apicomplexan 
parasites. Amino acid residues identical in at least three of the four sequences are highlighted in black; similar residues in gray. The amino-
terminal N-myristoylation motif in the GAP45 sequences is indicated with an asterisk. TgGAP45: T. gondii GAP45, GenBank/EBML/DDBJ 
accession no. AAP41369; NcGAP45: N. caninum GAP45 sequence, assembled from EST sequences with accession no. NcEST3c79 and 
NcEST3d11b08; PfGAP45: P. falciparum GAP45, accession no. AAN36304; PyGAP45: P. yoelii GAP45, accession no. EAA23022; CpGAP45: 
C. parvum GAP45, accession no. CAD98387. 
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is mediated by an integral membrane protein or through a
direct interaction with phospholipid head groups, in a man-
ner analogous to that proposed for myosin IC and I
 
 
 
 (Do-
berstein and Pollard, 1992; Reizes et al., 1994). In the case
of two class V myosins, Myo2p in 
 
Saccharomyces cerevisiae
 
and myosin-Va in melanocytes, specific receptors have been
identified on the membranes of cargo organelles, the yeast
vacuole and melanosome, respectively. In the melanocyte,
myosin-Va is linked by melanophilin to Rab27a that is, in
turn, associated with the melanosome membrane through
two geranylgeranyl moieties at its carboxy terminus (Wu et
al., 2002a,b). In 
 
S. cerevisiae
 
, Myo2p is linked by Vac17p
to Vac8p that is associated with the vacuole membrane
through an N-myristoyl and multiple palmitoyl groups at its
amino terminus (Ishikawa et al., 2003).
Here, we show that the two known components of the
 
Toxoplasma
 
 glideosome, TgMyoA and TgMLC1, are associ-
ated with two novel proteins, TgGAP45 and TgGAP50. Al-
though the function of TgGAP45 is not clear at this time,
TgGAP50 is an integral membrane glycoprotein that anchors
the glideosome in the inner membrane complex of 
 
T.
 
 
 
gondii
 
,
and thus performs a critical function in parasite motility.
 
Results
 
Identification of TgGAP45
 
As several factors required for 
 
Toxoplasma
 
 motility are known
to be associated with the parasite pellicle, we set out to iden-
tify additional structural and regulatory factors required for
parasite motility by a general characterization of the isolated
pellicle. Isolated pellicle preparations were subjected to se-
quential detergent extraction with Triton X-100 (TX100) and
sodium deoxycholate (DOC) to preferentially solubilize pro-
teins in the plasma membrane and inner membrane complex,
respectively (Mann and Beckers, 2001). Antisera were pro-
duced to the TX100- and DOC-soluble fractions, and these
were used to screen expression libraries of 
 
Toxoplasma
 
 cDNA.
Several of the reactive clones contained novel sequences and
were further characterized by the isolation of full-length cDNAs
and the production of monospecific antisera.
The antiserum to one of the clones detected with antisera
to the DOC-soluble fraction labels the periphery of parasites
in permeabilized (Fig. 1 A, GAP45) but not intact parasites
(unpublished data), suggesting it is associated with a cyto-
plasmic aspect of the 
 
Toxoplasma
 
 pellicle. However, the
staining pattern of this protein, TgGAP45, does not overlap
precisely with that of the plasma membrane marker SAG1.
Specifically, discontinuities are observed at the anterior end
of the parasite, suggesting the protein is associated with the
inner membrane complex rather than the plasma mem-
brane. To confirm this, immunofluorescence was performed
on parasites treated with 
 
Clostridium septicum
 
 
 
 
 
-toxin, which
causes their plasma membrane to swell away from the inner
membrane complex (Wichroski et al., 2002). After toxin
treatment, the staining patterns for TgGAP45 and SAG1 are
clearly distinct (Fig. 1 A), also suggesting that the protein is
present in the inner membrane complex of the parasite
rather than the plasma membrane.
To determine the exact localization of TgGAP45 in the
parasite, pellicle preparations were incubated with the mono-
specific antiserum, followed by gold-conjugated secondary
antibodies. In pellicle preparations subjected to sonication
one often sees regions where the plasma membrane is sepa-
rated from the underlying inner membrane complex. As can
be seen in Fig. 1 B, TgGAP45 antibodies react specifically
with the inner membrane complex, but not the plasma
membrane. Furthermore, the protein is clearly only found
on the side of the inner membrane complex that faces the
parasite plasma membrane. As this protein represented a
genuine pellicle protein and was found in a location associ-
ated with the parasite’s motile apparatus, it was analyzed in
greater detail.
Sequence analysis of full-length clones of TgGAP45 re-
vealed a single ORF of 735 bp, predicted to encode a pro-
tein of 245 amino acids with a molecular mass of 27.3 kD
(Fig. 1 C). Comparison of the predicted amino acid se-
quence to those of proteins with known function revealed
no strong homologies. However, we did find orthologues in
databases of genomic and EST sequences of the related para-
sites 
 
Neospora caninum
 
, 
 
Plasmodium falciparum
 
, 
 
Plasmodium
yoelii
 
, and 
 
Cryptosporidium parvum
 
. The predicted amino
acid sequences of these proteins demonstrate a high degree
of sequence homology at their carboxy termini (Fig. 1 C).
Further analysis of the predicted amino acid sequences of all
orthologues revealed regions with a high probability to form
a coiled-coil structure (unpublished data) and a potential
N-myristoylation site (Fig. 1 C).
When analyzed by immunoblot analysis, the TgGAP45
antiserum reacted with a single protein in 
 
Toxoplasma
 
 ly-
sates with an apparent molecular mass of 
 
 
 
45 kD (Fig. 2
Figure 2. GAP45 is associated with myosin-A, myosin light chain-1, 
and a novel 50-kD protein. (A) The TgGAP45 antiserum recognizes 
a single 45-kD protein on immunoblots. A Toxoplasma lysate was 
fractionated by SDS-PAGE and immunoblot analysis using either 
preimmune serum or a TgGAP45 antiserum. (B) Immunoprecipitation 
analysis with the TgGAP45 antiserum. Intracellular parasites were 
metabolically labeled with [
35S]-labeled methionine and cysteine, 
lysed in a buffer containing either SDS or TX100, and subjected to 
immunoprecipitation with the TgGAP45 antiserum. Only one protein, 
GAP45, is immunoprecipitated from denaturing extracts prepared 
with SDS, whereas three additional proteins are immunoprecipitated 
from TX100 extracts. (C) Metabolically labeled parasites or HFF 
cells were lysed in TX100-containing buffer and subjected to 
immunoprecipitation with the TgGAP45 antiserum. The immune 
complex was subjected to SDS-PAGE and transferred to nitrocellulose. 
Different molecular mass ranges of the blot were excised and incubated 
with monospecific antisera to TgMyoA, TgGAP45, and TgMLC1; 
each recognize their respective proteins in the immunoprecipitated 
complex. Asterisks indicate the IgG heavy and light chains that cross 
react with the secondary antibody used. 
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A), larger than the predicted molecular mass of 27.3 kD.
As recombinant fusion proteins containing the putative
coiled-coil domain (but not the remainder of the protein)
display a similar anomalous migration behavior during
SDS-PAGE, we believe this to be due to an elongated
structure or the high content of charged residues (unpub-
lished data).
 
TgGAP45 is associated with 
 
Toxoplasma
 
 myosin-A, 
myosin light chain-1, and a novel protein TgGAP50
 
As the predicted amino acid sequence did not reveal any
obvious functional homology to known proteins, we ana-
lyzed this protein by immunoprecipitation from metaboli-
cally labeled parasites. When cells are lysed and denatured
in an SDS-containing buffer, only a single 45-kD protein
is detected in immunoprecipitates (Fig. 2 B). However,
when cells are lysed in a TX100-containing buffer, three
additional proteins are immunoprecipitated with appar-
ent molecular masses of 93, 50, and 32 kD (Fig. 2 B).
When this immunoprecipitate is further analyzed by im-
munoblotting with an antiserum to TgGAP45, only the
45-kD subunit reacted (Fig. 2 C; unpublished data), sug-
gesting the other proteins are tightly associated, unrelated
proteins.
Considering the fact that TgGAP45 is found in the 
 
Toxo-
plasma
 
 pellicle and that the associated 93- and 32-kD pro-
teins are similar in size to the pellicle-associated myosin-A
(TgMyoA) and its associated light chain (TgMLC1), we an-
alyzed the immunoprecipitates with antisera to both pro-
teins. As is shown in Fig. 2 C, the 93- and 32-kD proteins
do indeed react with antisera to TgMyoA and TgMLC1, re-
spectively. All TgMyoA and TgMLC1 in the parasite is ap-
parently associated with TgGAP45, as judged by immuno-
blot analysis of parasite extracts after immunodepletion of
TgGAP45 (unpublished data). However, the 50-kD protein
does not react with any of the antisera used, suggesting it
represents a novel protein, and is henceforth referred to as
TgGAP50.
As the complex of TgMyoA and TgMLC1 has been dem-
onstrated to participate in the gliding motility of 
 
Toxoplasma
 
and other apicomplexan parasites, it has been named the
glideosome (Opitz and Soldati, 2002). Based on their associ-
ation with this complex and their apparent molecular mass,
the two novel proteins will therefore be referred to as glid-
Figure 3. Multiple alignment of Toxoplasma GAP50 with its apicomplexan orthologues and rat purple acid phosphatase. The predicted 
amino acid sequence of TgGAP50 was aligned with its orthologues in P. falciparum, P. yoelii, and E. tenella and with rat purple acid phosphatase 
using ClustalW. Amino acid residues identical in at least three of the four sequences are highlighted in black; similar residues in gray. Arrow 
indicates the amino terminus of mature TgGAP50 as determined by direct protein sequencing. Lines indicate the sequences of tryptic peptides 
of TgGAP50 as determined by mass spectroscopy. The putative carboxy-terminal transmembrane domain of TgGAP50 is boxed. Potential N-linked 
glycosylation sites in TgGAP50 and EtGAP50 and actual sites in the rat phosphatase are indicated by “###.” The amino acid residues in rat 
APP5 required for metal binding and enzymatic activity are labeled with asterisks. TgGAP50: T. gondii GAP50, GenBank/EBML/DDBJ 
accession no. AY587763; EtGAP50: E. tenella GAP50, this sequence was generated from unassembled shotgun reads of the E. tenella genome 
available at http://www.sanger.ac.uk/Projects/E_tenella/; PfGAP50: P. falciparum GAP50, accession no. NP_704719; PyGAP50: P. yoelii GAP50, 
accession no. EAA16957; RnAPP5: rat tartrate-resistant acid phosphatase type 5 precursor, accession no. P29288. 
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ing-associated protein (GAP) 45 and 50, or TgGAP45 and
TgGAP50.
To determine the relative composition of this complex, we
labeled parasite proteins to steady state with [
 
35
 
S]-labeled me-
thionine and cysteine and quantitated the amount of each
subunit by phosphorimaging analysis, correcting for the
number of methionine and cysteine residues in the predicted
sequence of each protein. TgMyoA, TgGAP50, TgGAP45,
and TgMLC1 were found to be present in a ratio of 1:1.42
(
 
 
 
0.21):1.31 (
 
 
 
0.21):1.38 (
 
 
 
0.21) (
 
n
 
 
 
 
 
 2, 
 
 
 
 SD), respec-
tively. Although these data are consistent with the glideosome
being a heterotetrameric complex of one copy of each pro-
tein, further analysis is needed to confirm this.
 
TgGAP50 is an integral membrane glycoprotein of the 
inner membrane complex
 
TgGAP50 was purified by preparative two-dimensional gel
electrophoresis, and tryptic digests were analyzed by mass
spectroscopy. The amino acid sequences of four tryptic frag-
ments were obtained and used to identify a candidate gene
in the database of 
 
Toxoplasma
 
 genomic DNA. The complete
ORF was subsequently identified by RT-PCR analysis and
isolation of a full-length cDNA clone. The TgGAP50 ORF
predicts a 431-residue protein with a predicted molecular
mass of 46.6 kD. Analysis of the predicted amino acid se-
quence reveals the presence of putative transmembrane do-
mains at the amino terminus (residues 25–45) and the ex-
treme carboxy terminus (residues 402–426), suggesting that
TgGAP50 is an integral membrane protein (Fig. 3).
Database searches reveal the presence of orthologues in
three other apicomplexan parasites: 
 
P.
 
 
 
falciparum
 
, 
 
P.
 
 
 
yoelii
 
,
and 
 
Eimeria tenella
 
 (Fig. 3). These proteins are highly ho-
mologous (41–58% identity) along their entire sequences,
except for the amino-terminal signal peptides, which
show little or no similarity. Therefore, it is likely that the
TgGAP50 orthologues perform similar functions in the mo-
tility of all apicomplexan parasites. Interestingly, TgGAP50
demonstrates a 22–26% identity to various purple acid
phosphatases of plants and animals, although the amino acid
residues critical for enzymatic activity of these phosphatases
were mostly not conserved in the sequence of 
 
Toxoplasma
 
TgGAP50 or its apicomplexan orthologues (Fig. 3).
The amino-terminal transmembrane domain of Tg-
GAP50 appears to act as a cleavable signal peptide, as direct
amino acid sequencing of purified protein reveals that the
amino terminus of the mature protein corresponds to resi-
due 51 in the predicted sequence. As the predicted molecu-
lar mass of the mature protein was smaller than that ob-
served in SDS-PAGE and as the TgGAP50 sequence is pre-
dicted to have three N-linked glycosylation sites (Fig. 3), we
subjected immunoprecipitates to digestion with the en-
doglycosidase PNGase-F. As can be seen in Fig. 4, this
results in a substantial decrease in molecular mass of Tg-
GAP50 to a value close to the one predicted for the mature
protein. This result demonstrates that TgGAP50 is indeed
N-glycosylated in 
 
Toxoplasma
 
. The decrease in molecular
mass is consistent with the removal of about three N-linked
glycans, suggesting that all three predicted glycosylation sites
are indeed used.
When a fusion protein of TgGAP50 and YFP is expressed
in 
 
T.
 
 
 
gondii
 
, it is efficiently targeted to the inner membrane
complex of mature parasites and growing daughter parasites
(Fig. 5), and is not present in the parasite plasma membrane
as judged by the following observations. In nonreplicating
parasites, TgGAP50-YFP colocalizes with the cell surface
marker SAG1 except at the extreme apical end of the organ-
ism, a region that lacks the inner membrane complex (Fig. 5
A, arrows). Treatment of these parasites with 
 
C. septicum
 
 
 
-toxin, which induces selective swelling of the plasma mem-
brane without affecting inner membrane complex morphol-
ogy (Wichroski et al., 2002), results in clear separation of
the plasma membrane marker SAG1 and TgGAP50-YFP
(Fig. 5 A). Together, these observations indicate that Tg-
GAP50 is an integral membrane protein of the inner mem-
brane complex rather than the plasma membrane. This con-
clusion is supported by the observation that in replicating
parasites, TgGAP50-YFP colocalizes with the inner mem-
brane complex–associated protein TgIMC1 (Mann and
Beckers, 2001) in the mother cell and enclosed daughter
parasites (Fig. 5 B).
Parasites expressing TgGAP50-YFP in a stable fashion
were metabolically labeled and analyzed by immunoprecipi-
tation with antisera to TgGAP45 and to GFP, which cross
reacts with YFP. When these parasites were lysed and dena-
tured in SDS, the GFP antiserum immunoprecipitates only
a single protein of 
 
 
 
82 kD, consistent with the predicted
molecular mass of the TgGAP50-YFP fusion protein (Fig. 6
A). However, when parasites were lysed in TX100-contain-
ing buffers, the GFP antiserum immunoprecipitated the
TgGAP50-YFP protein together with TgMyoA, TgMLC1,
and TgGAP45, but no untagged TgGAP50 (Fig. 6 A). In
this immunoprecipitate, TgGAP50-YFP was clearly present
in excess of the other subunits, suggesting that a substantial
fraction of this protein is not present in glideosomes. Tg-
GAP45 antiserum immunoprecipitates TgMyoA, TgGAP50,
TgGAP45, and TgMLC1 from these parasites, along with
the TgGAP50-YFP fusion protein (Fig. 6 A).
Combined, these data indicate that mature TgGAP50 is
an integral membrane protein of the 
 
Toxoplasma
 
 inner
membrane complex containing a 351-residue lumenal do-
Figure 4. Toxoplasma GAP50 is modified by N-linked glycosylation. 
The glideosome complex was immunoprecipitated from metabolically 
labeled parasites and was incubated in either the absence or presence 
of PNGase-F. Bands corresponding to the fully glycosylated and 
deglycosylated TgGAP50 are indicated.388 The Journal of Cell Biology | Volume 165, Number 3, 2004
main with N-linked glycans at residues 101, 136, and 228, a
single transmembrane domain, and a six-residue cytoplasmic
domain at the carboxy terminus. TgGAP50 is part of the
glideosome complex along with TgGAP45, TgMyoA, and
TgMLC1. As TgGAP50 is the transmembrane protein in
this complex, it is likely to act as the membrane anchor for
the glideosome, and thus to play a pivotal role in parasite
motility. The presence of highly conserved orthologues in
other apicomplexan parasites suggests the function of Tg-
GAP50 is conserved throughout this phylum.
The glideosome is assembled in two stages
Immunofluorescence analysis of Toxoplasma expressing the
TgGAP50-YFP fusion protein reveals a distinct difference in
the localization of the different components of the glideo-
some. TgGAP50 is found in the inner membrane complex of
both mature parasites and immature daughters, as judged by
its colocalization with the marker TgIMC1 (Fig. 5). In con-
trast, TgMyoA, TgMLC1, and TgGAP45 are only found as-
sociated with the inner membrane complex of mature para-
sites and are entirely absent from immature daughters (Fig.
5). This observation suggests that the glideosome may be as-
sembled in multiple stages during cell division in T. gondii.
To test this hypothesis, we used pulse-chase analysis and
immunoprecipitation with TgGAP45 antiserum to determine
if there were any changes in glideosome composition over
time. As can be seen in Fig. 7 A, a complex containing Tg-
MyoA, TgMLC1, and TgGAP45 can be isolated after a 15-
min pulse labeling, but TgGAP50 is absent. In contrast, after
a 4-h chase, all glideosome subunits, including TgGAP50, are
present in the complex. Together with the data in Fig. 5,
these observations demonstrate that the glideosome complex
is assembled in two stages. During or shortly after their syn-
thesis, the three glideosome subunits synthesized on cytoplas-
mic ribosomes, TgMyoA, TgMLC1, and TgGAP45, associ-
ate with each other into a complex, the proto-glideosome.
TgGAP50, on the other hand, is cotranslationally inserted
into the parasite ER and is transported to the inner mem-
brane complex where, in mature parasites, it associates with
the TgMyoA/TgGAP45/TgMLC1 proto-glideosome to form
the functional, membrane-associated glideosome.
GAP50 acts as the membrane anchor for the glideosome
If TgGAP50 acts as the membrane anchor of the glideosome
complex, one would predict that association of the glideo-
some with membranes would be dependent on the presence
of TgGAP50 in the complex. To test this hypothesis, we
separated homogenates of pulse-labeled and chased parasites
into soluble and particulate fractions and immunoprecipi-
tated from each the proto-glideosome and glideosome com-
plex using TgGAP45 antiserum. As can be seen in Fig. 7 B,
the proto-glideosome in pulse-labeled cells is found almost
entirely in the soluble fraction. The mature glideosome in
chased cells, in contrast, is largely present in the particulate
fraction. Together, the data in Fig. 7 clearly demonstrate
that the glideosome complex is assembled in distinct stages.
The TgMyoA, TgMLC1, and TgGAP45 subunits first as-
semble into a soluble proto-glideosome in the cytoplasm,
followed by its association with the membrane anchor
Figure 5. GAP50 is an inner membrane complex protein and 
the glideosome is assembled in two stages. (A) Distribution of 
TgGAP50-YFP was compared with that of the plasma membrane 
protein SAG1 in control cells and in parasites treated with C. septicum 
 -toxin. In untreated cells, the plasma membrane protein SAG1 is 
evenly distributed over the parasite circumference, whereas an 
anterior gap in TgGAP50-YFP distribution (arrows) is consistent with 
localization to the inner membrane complex. In toxin-treated para-
sites, the plasma membrane is markedly distended, whereas the 
distribution of TgGAP50-YFP is not affected, confirming its association 
with the inner membrane complex. Bars, 4  m. (B) Localization of 
glideosome components TgGAP50, TgGAP45, TgMyoA, and TgMLC1 
relative to each other and the Toxoplasma plasma membrane and 
inner membrane complex was determined by immunofluorescence 
analysis of Toxoplasma expressing a TgGAP50-YFP fusion protein 
and HA-tagged TgMyoA. TgGAP45 and TgMLC1 were detected using 
monospecific antisera and HA-TgMyoA using an anti-HA epitope 
mAb. TgGAP50 is found in the inner membrane complexes of both 
the mature parasite and immature daughter parasites. In contrast, 
TgMyoA, TgMLC1, and TgGAP45 are only found associated with 
the inner membrane complex of the mature parasite. Bars, 4  m. 
The diagram shows the localization of the plasma membrane of a 
mother parasite and of the inner membrane complexes of mother 
and daughter parasites. The inner membrane complex was detected 
using monospecific antisera to TgIMC1.Class XIV myosin membrane receptor in Toxoplasma | Gaskins et al. 389
TgGAP50 and formation of the glideosome proper on the
inner membrane complex.
Because the association of the proto-glideosome with
TgGAP50 most likely occurs through the latter’s short car-
boxy-terminal cytoplasmic domain, we generated a mutant
TgGAP50-YFP fusion protein, TgGAP50 (427-431)YFP,
in which this entire domain was deleted. Although expres-
sion of the full-length TgGAP50-YFP is not deleterious to
the parasite and stable transfectants can be obtained with
ease, we were unable to obtain stably transfected parasites
expressing TgGAP50 (427-431)YFP. In fact, at 48 h after
transfection 20–40% of parasites expressed normal Tg-
GAP50-YFP, but no parasites expressing the mutant protein
were observed at that time. This observation indicates that
expression of TgGAP50 (427-431)YFP exerts a dominant
lethal effect on Toxoplasma.
To determine whether this was due to an effect on assembly
of the glideosome, Toxoplasma transiently expressing this con-
struct were metabolically labeled 24 h after transfection and
subjected to immunoprecipitation with antisera to TgGAP45
or GFP. Unlike full-length TgGAP50-YFP, TgGAP50 (427-
431)YFP does not associate with the other glideosome sub-
units (Fig. 6 B), suggesting that the carboxy-terminal cytoplas-
mic domain is indeed essential for that process.
Discussion
The gliding movement of T. gondii and other apicomplexan
parasites appears to be mediated by the interaction of a myo-
sin motor with plasma membrane–associated actin filaments
(Jewett and Sibley, 2003). Here, we report on the discovery
of two novel proteins, TgGAP45 and TgGAP50, found as-
sociated with the major myosin heavy and light chains of
Toxoplasma, TgMyoA and TgMLC1. The term glideosome
has been used previously to describe the complex of Tg-
MyoA and TgMLC1 (Opitz and Soldati, 2002); we propose
here to update its definition to also include TgGAP45 and
TgGAP50. Preliminary analysis of the subunit stoichiome-
try in this complex suggests it may be composed of one
copy of each protein. TgGAP45 is associated with the outer
face of the inner membrane complex in mature parasites.
TgGAP50, on the other hand, is an integral membrane gly-
coprotein found in the inner membrane complex of both
mature and immature parasites. This protein also is the first
membrane protein identified in that structure in apicom-
plexan parasites.
The role of TgGAP45 is not clear at this time, although
the failure to obtain viable parasites with a disrupted Tg-
GAP45 gene using various strategies (Kim et al., 1993;
Figure 6. The carboxy-terminal cytoplasmic tail 
of TgGAP50 interacts with the other members of 
the glideosome complex. (A) Toxoplasma expressing 
a TgGAP50-YFP fusion protein and nontransfected 
parasites were metabolically labeled with [
35S]-
labeled methionine and cysteine and after lysis in 
either SDS or TX100 lysis buffer subjected to 
immunoprecipitation with antiserum to TgGAP45 
or GFP, which cross reacts with YFP. The other 
three members of the complex are coimmunopre-
cipitated with TgGAP50-YFP. (B) Toxoplasma tran-
siently expressing a TgGAP50 (427-431)YFP 
fusion protein were metabolically labeled with 
[
35S]-labeled methionine and cysteine, and after 
lysis in TX100 lysis buffer were subjected to immuno-
precipitation with antisera to either TgGAP45 or 
GFP. The prominent 40-kD band (A, asterisk) is a 
breakdown product of TgGAP45. Unlike full-length 
TgGAP50-YFP, TgGAP50 tail-YFP does not interact 
with the glideosome complex.
Figure 7. The glideosome complex is assembled 
in two stages and the presence of GAP50 correlates 
with membrane association. (A) Parallel cultures 
of Toxoplasma-infected HFF cells were metabolically 
labeled for 15 min at 37 C with [
35S]-labeled 
methionine and cysteine, and were either placed 
on ice (pulse) or incubated for an additional 4 h 
at 37 C after addition of unlabeled amino acids 
(chase). Parasites were isolated, lysed in TX100 
lysis buffer, and subjected to immunoprecipitation 
with TgGAP45 antiserum. (B) Parallel cultures of 
Toxoplasma-infected HFF cells were pulse labeled 
and chased as described above. Parasites were 
homogenized by sonication and an aliquot was 
fractionated into soluble (SN) and particulate (P) 
fractions by centrifugation. These were solubilized 
in TX100 lysis buffer along with the nonfractionated sample and subjected to immunoprecipitation with the TgGAP45 antiserum. We routinely 
observed that TgGAP45 in the pulsed sample migrated as a doublet, irrespective of whether it was solubilized in TX100 or SDS.390 The Journal of Cell Biology | Volume 165, Number 3, 2004
Donald and Roos, 1994, 1998; Meissner et al., 2002) sug-
gests it is essential (unpublished data). Expression of various
TgGAP45 mutants under the control of inducible (Meissner
et al., 2001) and constitutive promoters have thus failed to
affect normal glideosome assembly or parasite infectivity,
possibly due to the low level of expression ( 2–3% of the
wild-type protein) typically observed (unpublished data).
TgGAP50 is an essential protein by the same criteria (un-
published data). Biochemical and genetic analysis of Tg-
GAP50 suggests that this protein serves to anchor the
complex of TgMyoA, TgMLC1, and TgGAP45 in the
membrane of the inner membrane complex that faces
the parasite plasma membrane.
Conflicting observations have been published on the lo-
calization of apicomplexan myosin-A homologues. TgMyoA
was originally believed to be associated with the plasma
membrane (Dobrowolski et al., 1997), although the same
group has since suggested these observations may have been
erroneous (Jewett and Sibley, 2003). Recent evidence in P.
yoelii suggests that its myosin-A is associated with the inner
membrane complex (Bergman et al., 2003). Our observa-
tions support the latter model in that the complex of Tg-
MyoA, TgMLC1, TgGAP45, and TgGAP50 appears to be
associated with the inner membrane complex of Toxoplasma
rather than the plasma membrane.
All apicomplexan parasites for which sequence data are
available possess highly similar orthologues of TgGAP45
and TgGAP50, suggesting that their function is conserved
throughout the entire phylum. The apicomplexan TgGAP45
proteins all possess amino-terminal myristoylation motifs and
a highly conserved carboxy-terminal domain, separated by
poorly conserved domains that share a high propensity to
form coiled coils. The apicomplexan GAP50 proteins also
demonstrate a high degree of sequence similarity, except in
their amino-terminal signal sequences. The predicted lume-
nal, cytoplasmic, and even transmembrane domains are
highly conserved amongst these proteins. The lumenal do-
mains of the apicomplexan GAP50 proteins are also surpris-
ingly similar to the purple acid or tartrate-resistant phos-
phatases, a family of secreted enzymes found in animals and
plants (Oddie et al., 2000; Schenk et al., 2000). However,
the amino acid residues critical to phosphatase activity
(Oddie et al., 2000) are mostly not conserved in the apicom-
plexan GAP50 proteins, suggesting they are not phos-
phatases. This notion is supported by our inability to de-
tect  phosphatase activity in preparations of recombinant
TgGAP50 (unpublished data). However, the high degree of
similarity does suggest that there may be substantial similari-
ties in the secondary and tertiary structure of the lumenal do-
mains of apicomplexan GAP50 proteins and the purple acid
phosphatases. The high degree of sequence identity observed
in the transmembrane domains of the GAP50 proteins is sur-
prising and may indicate that this domain interacts in a spe-
cific manner with other membrane-embedded components
of the inner membrane complex. The near identity of the
short carboxy-terminal cytoplasmic domains of the GAP50
proteins probably reflects its role in the interaction with other
members of the glideosome complex (see below).
The glideosome complex is assembled in two stages.
Pulse-chase analysis and subcellular fraction revealed that
TgMyoA, TgMLC1, and TgGAP45 are first assembled into
a soluble complex, the proto-glideosome. Subsequently, this
complex associates with the integral membrane protein
TgGAP50 and becomes anchored in the membrane, form-
ing the glideosome proper. The two-stage assembly of the
glideosome is also reflected in the subcellular distribution of
the different subunits. TgGAP50 is found in the inner
membrane complex of immature daughter parasites as well
as mature parasites. However, The proto-glideosome sub-
units TgGAP45, TgMyoA, and TgMLC1 are only found as-
sociated with the inner membrane complex of the mature
parasites. This suggests that the soluble proto-glideosome
and membrane-associated TgGAP50 are transported sepa-
rately from their site of synthesis in the cytoplasm and ER,
respectively, and are assembled into the glideosome in the
inner membrane complex of mature parasites.
The proto-glideosome most likely associates with the con-
served carboxy-terminal cytoplasmic domain of TgGAP50, as
the interaction is prevented by the deletion of this domain. It
is not known at this time which glideosome subunit interacts
with TgGAP50 and the manner in which this occurs. Al-
though TgMyoA and TgMLC1 could be shown to interact af-
ter in vitro translation (unpublished data), we were unsuccess-
ful in our attempts to detect interaction of TgGAP45 and
TgGAP50 with the other glideosome subunits using in vitro–
translated proteins and recombinant proteins (unpublished
data). This suggests that one or more of the subunits may need
to undergo cell cycle or parasite-specific post-translational
modifications for complex assembly to occur. These modifica-
tions may, in fact, be critical for controlling the two-stage as-
sembly of the glideosome we observed in living parasites.
The assembly of the glideosome in two stages may serve
several purposes for Toxoplasma. Most likely, it limits assem-
bly of the fully active glideosome to the location where it is
needed, the outer face of the inner membrane complex of
the mature parasite. However, it is also possible that the
proto-glideosome association with the cytoplasmic tail of
TgGAP50 is reversible, and thus offers a mechanism for
control of parasite motility.
In our working model of Toxoplasma motility, glideo-
somes on the inner membrane complex interact with actin
filaments that are associated with the adhesin MIC2 in the
parasite plasma membrane. This arrangement would allow
the glideosome to move with respect to the MIC2 anchored
on a host cell or other substrate. However, in order for this
to result in parasite motility it is critical that the glideosome
is not only attached to the inner membrane complex, but
also that it is immobilized within the plane of the mem-
brane. This could be accomplished most easily by direct or
indirect interaction of the glideosome with stable elements
of the Toxoplasma cytoskeleton. Such structures have not
been described on the side of the inner membrane complex
that faces the plasma membrane. However, on the cytoplas-
mic side a dense fibrillar network forms a membrane skele-
ton along the length of the parasite (Mann and Beckers,
2001). In addition, 22 microtubules are present on that side,
although these extend only partly along the length of the
parasite (Nichols and Chiappino, 1987). As the inner mem-
brane complex consists of two membranes, association of the
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the presence of structures that span both membranes. Freeze
fracture analysis of the inner membrane complex has in fact
revealed candidates that could fulfill this function in the
form of large numbers of intramembranous particles present
in both membranes and distributed in a manner suggesting
they are associated with both the membrane skeleton and
the microtubules (Morrissette et al., 1997). Experiments are
in progress addressing, in general, the immobilization of
the glideosome and specifically its association with the in-
tramembranous particles. The possibility that TgGAP50
may, in fact, interact directly or indirectly with the cytoskel-
eton is suggested by the observation that expression of a mu-
tant TgGAP50 lacking its cytoplasmic domain is lethal for
Toxoplasma. As expression of this protein does not disrupt
assembly of the glideosome on endogenous TgGAP50, its
lethality may be explained by a dominant disruption of the
glideosome–cytoskeleton interaction.
The identification in T. gondii of TgGAP50 as the recep-
tor for a complex of TgMyoA, TgMLC1, and TgGAP45 in
the inner membrane complex provides the first evidence that
the class XIV myosins in apicomplexan parasites associate
with membranes through interaction with a transmembrane
protein. Further analyses are needed to determine how the
different subunits interact with each other and how complex
assembly is controlled in the parasite. Moreover, identifica-
tion of the manner in which TgGAP50, and therefore the
glideosome as a whole, is immobilized in the plane of the in-
ner membrane complex is of critical importance in under-
standing the mechanism of gliding motility in Toxoplasma
and the other apicomplexan parasites.
Materials and methods
Culture of Toxoplasma and isolation of pellicle proteins
The RH (HXGPRT
 ) strain of Toxoplasma was maintained as described
previously (Mann et al., 2002). A pellicle fraction was prepared from 4  
10
9 parasites by sonication and differential centrifugation as described pre-
viously (Mann and Beckers, 2001). This fraction was extracted in 1%
TX100 in PBS and 1 mM PMSF for 10 min on ice. TX100-insoluble mate-
rial was collected by centrifugation at 10,000 rpm for 10 min, washed
once in 1% TX100 in PBS, and extracted for 10 min on ice in 1% DOC in
PBS and PMSF. DOC-soluble material was separated from insoluble mate-
rial by centrifugation as above. The TX100- and DOC-soluble fractions
were used to immunize two mice by subcutaneous injection (Cocalico Bi-
ologicals, Inc.).
Library screening with anti-pellicle antisera
A T. gondii cDNA library in  ZAPII (AIDS Research and Reference Reagent
Program, McKesson Biosciences, Rockville, MD) was screened using anti-
sera to pellicle proteins with the ProtoBlot
® Immunoscreening System
(Promega). Positive clones were initially grouped based on restriction en-
zyme digestion patterns, and a single representative of each group was se-
quenced (Keck Biotechnology Resource Laboratory, Yale University, New
Haven, CT).
Preparation of monospecific antisera to recombinant TgGAP45
For production of monospecific antisera to TgGAP45, a BamHI and XhoI
fragment containing the carboxy-terminal 72 amino acids of the predicted
ORF was inserted in-frame behind GST in pGEX2 (Amersham Biosciences).
GST-GAP45 fusion protein was expressed in Escherichia coli JM109 and pu-
rified on glutathione-agarose (Sigma-Aldrich). The fusion protein was used to
immunize mice and rabbits (Cocalico Biologicals, Inc.).
Metabolic labeling of T. gondii
Parasites were allowed to invade a monolayer of human foreskin fibroblast
(HFF) cells. After 14–16 h, cells were incubated in methionine/cysteine-
free medium (Mediatech) for 1 h before addition of 0.1 mCi [
35S]-labeled
methionine/cysteine (Amersham Biosciences) per ml medium. Parasites
were harvested on ice after a 20–24-h incubation at 37 C.
To perform pulse-chase experiments, HFF cells grown in multiple flasks
were infected and starved in methionine/cysteine-free medium as de-
scribed above. To each flask, 0.25 mCi [
35S]-labeled methionine/cysteine
was added per ml of label medium. After 15 min at 37 C, one flask (pulse)
was placed on ice. Unlabeled methionine and cysteine were added to the
other flasks to final concentrations of 1 and 0.2 mM, respectively, and
these were incubated at 37 C for the time indicated.
Immunoprecipitation of the glideosome
Parasites (5–10   10
7/ml) were lysed with 1% TX100 or 1% SDS in the
presence of protease inhibitors (P8340; Sigma-Aldrich). For TX100 lysis,
cells were resuspended in IP buffer (1% TX100, 50 mM Tris-Cl, pH 8.0,
150 mM NaCl, and 5 mM EDTA). For SDS lysis, cells were resuspended in
100  l 1% SDS in water plus protease inhibitors and heated for 5 min at
95 C, followed by ninefold dilution in IP buffer. SDS- or TX100-lysed cells
were incubated on ice for 10 min, followed by centrifugation at 14,000
rpm for 10 min at 4 C. The supernatant was incubated at 4 C for 1 h with
anti-GAP45 or anti-GFP antisera. Protein A–Sepharose (Zymed Laborato-
ries) was added and the incubation was continued for 30 min at 4 C. Im-
mune complexes were washed three times in IP buffer and separated by
SDS-PAGE. Gels containing radiolabeled immune complexes were sub-
jected to fluorography using Enhance (NEN Life Science Products), dried,
and exposed to film.
PNGase-F treatment of immunoprecipitates was performed as suggested
by the manufacturer (Calbiochem). The protein A beads were resuspended
after the last wash in 25  l 50 mM sodium phosphate, pH 7.5, 50 mM
2-mercaptoethanol, and 0.1% SDS, and were heated for 5 min at 95 C. Af-
ter cooling and addition of TX100 to a final concentration of 1%, 5 U PNG-
ase-F was added and the mixture was incubated for 4 h at 37 C followed
by SDS-PAGE and fluorography as described above.
Subcellular fractionation
Toxoplasma-infected HFF cells were pulse labeled with [
35S]-labeled me-
thionine/cysteine as described above and either placed on ice or chased
for an additional 4 h at 37 C. Cells and parasites were collected as de-
scribed above and frozen in liquid nitrogen. After thawing on ice, cell pel-
lets were resuspended in 500  l TBS with 5 mM EDTA and protease inhib-
itors, and were subjected to five 10-s bursts in a cell disrupter (Misonix,
Inc.). Half of each homogenate was placed on ice and the remainder was
centrifuged for 30 min at 150,000 g in a rotor (SW55; Beckman Coulter).
TX100 was added to the total homogenate sample and the soluble fraction
to a final concentration of 1%. The particulate fraction was resuspended in
250  l IP buffer. After addition of protease inhibitors and a 10-min incuba-
tion on ice, all fractions were clarified by centrifugation for 10 min at
14,000 g and analyzed by immunoprecipitation with TgGAP45 antiserum
as described above.
Mass spectroscopy, protein sequencing, and cloning of TgGAP50
The glideosome complex was isolated from 10
9 parasites using anti-
GAP45 antibodies covalently attached to CnBr-activated Sepharose-4B
(Amersham Biosciences). Bound proteins were eluted using 7 M urea, 2 M
thiourea, 2% ASB-14, 2% ampholytes 3-10, and 50 mM Tris, and were
separated by two-dimensional electrophoresis using a pH 4–7 IPG strip
(Bio-Rad Laboratories) in the first dimension and SDS-PAGE in the second
dimension. Proteins of interest were detected by staining with Coomassie
brilliant blue, excised, and subjected to in-gel digestion using trypsin.
Tryptic peptides were analyzed by lipid chromatography coupled with tan-
dem mass spectroscopy at the Mass Spectrometry Shared Facility in the
UAB Comprehensive Cancer Center (University of Alabama at Birming-
ham, Birmingham, Alabama).
For direct sequencing of the TgGAP50 amino terminus, the glideosome
proteins were transferred, after two-dimensional electrophoresis, to PVDF
membrane (Bio-Rad Laboratories). The TgGAP50 spot was excised after
staining with Coomassie brilliant blue and subjected to direct amino acid
sequencing at the Protein Chemistry Facility of the UAB Comprehensive
Cancer Center.
Toxoplasma genomic DNA and mRNA sequences in ToxoDB encoding
TgGAP50 were identified using the peptide sequences obtained by mass
spectroscopy. The complete predicted ORF and stop codon of TgGAP50
was amplified from total Toxoplasma RNA by RT-PCR using Pfu Turbo
DNA polymerase (Stratagene) and the primers 5 -gcagatctaaaATGGCAG-
GCGCCCCCGTCGCGGCCGCC-3  and 5 -gccctaggTTATTTCATGTAGC-
GAGAGAGACCGTTC-3 . This PCR product was cloned into the TOPO
®-
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encoding the TgGAP50 ORF and flanking regions were isolated from a li-
brary of Toxoplasma cDNA in  ZAPII (AIDS Research and Reference Re-
agent Program) and sequenced in their entirety.
Plasmid construction and expression in Toxoplasma
To generate the TgGAP50-YFP construct, the ORF was amplified using the
primers 5 -gcagatctaaaATGGCAGGCGCCCCCGTC-3  and 5 -gccctag-
gTTTCATGTAGCGAGAGAG-3 . The PCR product was digested with BglII
and AvrII and inserted between the BglII and AvrII sites in ptub -IMC1-
YFP/sagCAT (Hu et al., 2002). To generate the TgGAP50 (427-431)YFP
construct, the ORF minus the six carboxy-terminal residues was amplified
using the same forward primer as above and the reverse primer 5 -gccctag-
gACCGTTCGCGACAGAGAG-3 , digested with BglII and AvrII, and in-
serted between the BglII and AvrII sites in ptub -IMC1-YFP/sagCAT.
TgGAP50-YFP and TgGAP50 (427-431)YFP constructs were trans-
fected into Toxoplasma by electroporation, and stable transfectants ex-
pressing TgGAP50-YFP were obtained by selection with chloramphenicol
(Mann et al., 2002) and cloning by limiting dilution.
The HA-TgMyoA construct was amplified using primers 5 -cgggatc-
cATGGCGAGCAAGACCACGTC-3  and 5 -GTCTAGAACGCCGGCTGA-
ACAAGTCG-3 . The resulting PCR product was digested with BamHI and
cloned between the BamHI and filled-in NotI sites of pEXP-NtermHA
(Mann et al., 2002). The HA-TgMyoA construct was transfected into Toxo-
plasma expressing TgGAP50-YFP as described above, and parasites were
analyzed by immunofluorescence 24 h after transfection.
Immunofluorescence and immuno-EM
Untreated extracellular parasites, parasites treated with C. septicum
 -toxin, or infected cells were fixed and permeabilized for 5 min in cold
( 20 C) methanol or for 15 min in 3% PFA and 0.25% glutaraldehyde in
PBS, and for 5 min in 1% TX100 in PBS. Epifluorescence microscopy was
performed as described previously (Mann et al., 2002) using a microscope
(model BX60; Olympus), and images were collected with a SPOT2 camera
(Diagnostic Instruments) and processed in Adobe Photoshop
®.
For the  -toxin experiments, parasites were treated with 20 nM toxin for
4 h and processed as described previously (Wichroski et al., 2002), except
that fixed and permeabilized parasites were incubated first with primary
antibody diluted at 1:2,000, followed by incubation with a 1:400 dilution
of Alexa Fluor
®–conjugated secondary antibody (Molecular Probes, Inc.).
For preembedding immuno-EM, isolated pellicles were incubated with
primary antibody (anti-TgGAP45 at 1:500) diluted in 3% BSA in PBS for 3 h
on ice. The sample was washed in PBS by sedimentation (10,000 rpm for
10 min) and resuspension. Incubation with 10-nm gold–conjugated goat
anti–mouse IgG secondary antibody (Sigma-Aldrich) diluted 1:25 in 3%
BSA in PBS was performed overnight at RT. The sample was washed in
PBS as described above and fixed in 1% glutaraldehyde in PBS for 20 min.
After another PBS wash, the sample was fixed in 1% osmium tetroxide in
PBS for 20 min, washed in PBS, dehydrated in increasing concentrations of
ethanol, embedded in Spurr’s resin (Electron Microscopy Sciences), and
polymerized overnight at 70 C. Thin sections were prepared, stained with
uranyl acetate and lead citrate, and observed with an electron microscope
(model H700; Hitachi).
SDS-PAGE and immunoblotting
Protein preparations were separated by SDS-PAGE on 12% polyacryl-
amide mini gels (Bio-Rad Laboratories). To obtain optimal resolution be-
tween TgGAP45 and TgGAP50, electrophoresis was continued for 15 min
at 150 V after the bromophenol blue front had run off the gel. Transfer to
nitrocellulose and immunoblot analysis was performed as described previ-
ously (Mann and Beckers, 2001).
Analysis of TgGAP45 and TgGAP50 sequences
DNA and predicted protein sequences were analyzed using BLAST and
FASTA. Multiple sequence alignments were performed using ClustalW.
Putative transmembrane domains were identified using TMHMM (http://
www.cbs.dtu.dk/services/TMHMM-2.0/) and HMMTOP (http://www.enzim.
hu/hmmtop/). Potential N-linked glycosylation sites were identified using
NetNGlyc (http://www.cbs.dtu.dk/services/NetNGlyc/). Preliminary geno-
mic and cDNA sequence data were accessed via http://ToxoDB.org. Se-
quence data for the P. falciparum genome were accessed via http://plasmodb.
org/ (Bahl et al., 2003).
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